A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a new study.
The study involved 53 men and women with an average age of 38. The participants were given a combination of several antiretroviral drugs known as Highly Active Anti-Retroviral Therapy (HAART) for one year. Researchers tested the participants’ cerebrospinal fluid before and after treatment to see if there were elevated levels of a particular biomarker for brain injury called neurofilament light protein.
The study found 21 people had high levels of the protein, suggestive of brain damage, at the beginning of treatment. But after three months of taking HAART, those high levels of protein fell to normal levels in nearly half of the patients. After one year of treatment, only four people still had high levels of this particular biomarker for brain damage.
In addition, for the 32 patients who had normal levels of the protein at the beginning of the study, all but one remained normal at follow-up.
“This type of treatment appears to halt the neurodegenerative process caused by HIV,” said study author Åsa Mellgren, MD, PhD, with the Clinic of Infectious Diseases SÄS in Borås, Sweden, and the Sahlgrenska Academy at Göteborg University in Göteborg, Sweden. “This study confirms that neurofilament light protein serves as a useful marker in monitoring brain injury in people with HIV and in evaluating the effectiveness of HAART.”
The study also found nine of the 21 people with high levels of the protein had dementia as a result of AIDS and their levels of the protein were significantly higher than those without dementia at the beginning of the study. “But four of these people with dementia did not see their levels return to normal by the end of the study,” said Mellgren. “It’s possible these levels may have reached normal limits if the study had been longer.”
Mellgren says a larger, longitudinal study of the protein is needed that includes more extensive neurological measures, including cognitive testing of the study participants.
The study was supported by grants from the National Institutes of Health, Göteborg University, and Research Foundation of Swedish Physicians against AIDS.
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Sam Ting On AMS Results: Dark Matter Might Be One Seminar Away
- Vitriolic Abuse Of Anita Sarkeesian: Why The Games Industry Needs Her
- Why Natural Gas, Including Fracking, Is Better For The Environment Than Wind And Solar
- Graphene Sensor Tracks Down Cancer Biomarkers
- BICEP2's vision wasn't that strong, Planck says their window was too dusty.
- Nature Communications Switching To Exclusive Open Access
- 15 Biomarkers: Blood Test May Determine Risk For Psychosis
- "1.) Fundamentally one can never prove any theory. That's what makes a theory different from..."
- "I thank you for your comment, which I think is very important. Especially the question aboutPerhaps..."
- "I know what you mean, that is why I wrote sim Evo in . ;-)..."
- "You derive this how? ;-)..."
- "Whoa, careful there. If you say something the blogger doesn't like, you might find it hidden due..."
- Does the belief in guardian angels make people more cautious?
- Aberrant PI3K/AKT/mTOR pathway found in vestibular schwanommas may be therapeutic target
- A multi-function protein is key to stopping genomic parasites from 'jumping'
- Presence or absence of early language delay alters anatomy of the brain in autism
- News from Annals of Internal Medicine tip sheet -- Sept. 23, 2014
Books By Writers Here